Plasmacytoid and micropapillary urothelial carcinoma: Rare forms of urothelial carcinoma;Das plasmazytoide und mikropapilläre Urothelkarzinom: Seltene Varianten eines Urothelkarzinoms

Urologe - Ausgabe A

Volumn 50, Issue 2, 2011, Pages 217-220

  Keck, B ^a   Stoehr, R ^a   Wach, S ^a   Rogler, A ^a   Nolte, E ^a   Hartmann, A ^a   Wullich, B ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aberrations; Histomorphology; Micropapillary urothelial carcinoma; Plasmacytoid urothelial carcinoma; Urinary bladder

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; GENETIC DISORDER; HUMAN; MICROPAPILLARY UROTHELIAL CARCINOMA; MOLECULAR MECHANICS; PLASMACYTOID UROTHELIAL CARCINOMA; PROGNOSIS; SMALL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, PAPILLARY; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 79952488478     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-010-2484-4     Document Type: Article

References (31)

1. Robert Koch-Institut (2010) Krebs in Deutschland 2005/2006. Häufigkeiten und Trends, 7. Aufl. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg) Berlin
2. Eble J, Sauter G, Epstein JI, Sesterhenn IA (Hrsg) (2004) Classification of tumours. Pathology and genetics of the tumours of the urinary system and male genital organs. World Health Organization, Lyon
3. Gaafar A, Garmendia M, de Miguel E et al (2008) Carcinoma urothelial plasmocitoide de vejiga urinaria. Estudio de 7 casos. Actas Urol Esp 32(8):806-810
4. Mai KT, Park PC, Yazdi HM et al (2006) Plasmacytoid transitional cell carcinoma. Report of seven new cases. Eur Urol 50:1111-1114
5. Fritsche HM, Burger M, Denzinger S et al (2008) Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases. J Urol 180:1923-1927
6. Black PC, Brown GA, Dinney CPN (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27(1):3-7
7. Kamat AM, Gee JR, Dinney CP et al (2006) The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 175(3 Pt 1):881-885 (Pubitemid 43200002)
8. Keck B, Stoehr R, Wach S et al (2010) The plasmacytoid carcinoma of the bladder - rare variant of aggressive urothelial carcinoma. Int J Cancer (Epub ahead of print)
9. Kamat AM, Dinney CP, Gee JR et al (2007) Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 110(1):62-67 (Pubitemid 46986419)
10. Lopez-Beltran A, Montironi R, Blanca A, Cheng L (2010) Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 41(8):1159-1164
11. Amin MB, Ro JY, el-Sharkawy T et al (1994) Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18(12):1224-1232 (Pubitemid 24362435)
12. Amin MB, Tamboli P, Merchant SH et al (2002) Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 26(3):358-364 (Pubitemid 34184460)
13. Siriaunkgul S, Tavassoli FA (1993) Invasive micropapillary carcinoma of the breast. Mod Pathol 6(6):660-662 (Pubitemid 2014261)
14. Smith Sehdev AE, Sehdev PS, Kurman RJ (2003) Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am J Surg Pathol 27(6):725-736 (Pubitemid 36617509)
15. Marchiò C, Iravani M, Natrajan R et al (2008) Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol 215(4):398-410
16. Weigelt B, Reis-Filho JS (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6(12):718-730
17. Baldwin L, Lee AH, Al-Talib RK, Theaker JM (2005) Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 46(1):50-56 (Pubitemid 40193698)
18. Nigwekar P, Tamboli P, Amin MB et al (2009) Plasmacytoid urothelial carcinoma detailed analysis of morphology with clinopathologic correlation in 17 cases. Am J Surg Pathol 33(3):417-424
19. Lotan TL, Ye H, Melamed J et al (2009) Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol 33(7):1037-1041
20. Alkibay T, Sözen S, Gürocak S et al (2009) Micropapillary pattern in urothelial carcinoma: a clinicopathological analysis. Urol Int 83(3):300-305
21. Amin MB, Ro JY, el-Sharkawy T et al (1994) Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18(12):1224-1232 (Pubitemid 24362435)
22. Johansson SL, Borghede G, Holmäng S (1999) Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol 161(6):1798-1802 (Pubitemid 29420734)
23. Kamat AM, Gee JR, Dinney CP et al (2006) The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 175(3 Pt 1):881-885 [Erratum in: J Urol 175(5):1967] (Pubitemid 43200002)
24. Van Oers JM, Wild PJ, Burger M et al (2007) FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumors. Eur Urol 52:760-768 (Pubitemid 47126132)
25. Malats N, Bustos A, Nascimento CM et al (2005) P53 as a prognostic marker for bladder cancer: A metaanalysis and review. Lancet Oncol 6:678-686 (Pubitemid 41222758)
26. Pfister C, Lacombe L, Vezina MC et al (1999) Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors. Hum Pathol 30(11):1350-1355 (Pubitemid 29534298)
27. Kovach JS, Hartmann A, Blaszyk H et al (1996) Mutation detection by highly sensitive methods indicates that p53 mutations in breast cancer may have important prognostic value. Proc Natl Acad Sci USA 93(3):1093-1096 (Pubitemid 26052847)
28. Van Rhijn BW, Vis AN, Kwast TH van der et al (2003) Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol 21(10):1912-1921 (Pubitemid 46606378)
29. Van Oers JM, Zwarthoff EC, Rehman I et al (2009) FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours. Eur Urol 55:650-657
30. Shimada K, Nakamura M, De Velasco MA et al (2010) Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma. Cancer Sci 101(1):155-160
31. Smaratunga H, Khoo K (2004) Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinopathological and immunohistochemical study. Histopathology 45(I):55-64 (Pubitemid 38969562)